id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1999-D-0010-0002,FDA,FDA-1999-D-0010,Guidance for Industry on Levothyroxine Sodium Tablets-In Vivo Pharmacokinetic and Bioavailability Studies and in Vitro Dissolution Testing; Availability,Notice,Notice of Data Availability,2001-03-09T00:00:00Z,2001,3,,,2025-05-27T16:19:59Z,01-5610,0,0,09000064804a59f2